FDAsafety guidance66% confidence
Compounding Quality Center of Excellence | Instructor-Led Trainings
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Azurity Pharmaceuticals; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
The Compounding Quality Center of Excellence’s free in-person training programs target outsourcing facility staff and offer continuing education credits. The training will open for state regulators and pharmacy compounders if space is available.
Supporting Context
- Therapeutic area
- Pharmaceuticals · Compounding
- Sub-indication
- General
Related signal: FDA Orders Azurity Pharmaceuticals to Halt Distribution of Unapproved Compounding Kits